Our Areas of Focus
Vertex’s business development activities are focused on complementing our internal research and development capabilities with external innovation that may help further our mission to bring new medicines to people with serious diseases. We seek to collaborate with companies and organizations that are researching and developing cutting-edge medicines. We welcome inquiries related to establishing new collaborations related to both development-stage programs and to new drug discovery and development technologies that could complement our own internal capabilities.
We are focused on the following diseases and related areas:
- Infectious diseases
- Liver-related diseases
- Autoimmune diseases
- Specialty respiratory diseases (especially those associated with cystic fibrosis)
- Fibrotic disorders
- Neurodegenerative diseases
- Orphan diseases
Vertex has historically been focused on developing small molecule medicines, but we are open to exploring other approaches that may change the treatment of a serious disease where no adequate treatment currently exists. In addition, we are also seeking platform technologies that will enable exploration of new diseases or disease targets that have previously been difficult to explore.
Learn more about: